Aethlon Medical (AEMD) Return on Sales (2011 - 2023)

Aethlon Medical's Return on Sales history runs 13 years deep, the most recent figure standing at 0.04% for Q1 2023.

• For the quarter ending Q1 2023, Return on Sales rose 284.0% year-over-year to 0.04%; the trailing twelve-month figure through Mar 2023 stood at 0.21% (up 15.0% YoY), and the FY2023 full-year result was 0.21%, up 15.0% from the prior year.
• Return on Sales was 0.04% for Q1 2023 at Aethlon Medical, up from 10.07% in the prior quarter.
• Over the last five years, Return on Sales for AEMD reached as high as 0.02% in Q4 2019 and fell as low as 10.07% in Q4 2022.
• Median Return on Sales over the past 5 years was 0.21% (2019), compared with a mean of 1.3%.
• Across the five-year window, Return on Sales sank 859 bps in 2022 and jumped 284 bps in 2023, its largest moves.
• Over 5 years, Return on Sales stood at 0.02% in 2019, then sank by 85 bps to 0.04% in 2020, then slumped by 3674 bps to 1.48% in 2021, then plunged by 582 bps to 10.07% in 2022, then soared by 100 bps to 0.04% in 2023.
• Business Quant data shows AEMD's Return on Sales at 0.04% in Q1 2023, 10.07% in Q4 2022, and 4.26% in Q3 2022.